-
CiteScore
-
Impact Factor
Volume 1, Issue 1, IECE Transactions on Advanced Computing and Systems
Volume 1, Issue 1, 2024
Submit Manuscript Edit a Special Issue
Academic Editor
Xue-Bo JIN
Xue-Bo JIN
Beijing Technology and Business University, China
Article QR Code
Article QR Code
Scan the QR code for reading
Popular articles
IECE Transactions on Advanced Computing and Systems, Volume 1, Issue 1, 2024: 19-31

Free to Read | Research Article | 18 February 2025
Prediction of Coronavirus Inhibitors in Drug Discovery through Deep Learning
1 Department of Computer Science, COMSATS University Islamabad, Abbottabad Campus, Pakistan
2 School of Computer Science and Technology, Chongqing University of Posts and Telecommunications, Chongqing 400065, China
3 School of Computer Science and Technology, Zhejiang Gongshang University, Hangzhou 310018, China
4 School of Artificial Intelligence, Nanjing University of Information Science & Technology, Nanjing 210044, China
5 College of Mechatronics and Control Engineering, Shenzhen University, Shenzhen 518060, China
6 Computer Science Department, Institute of Business Management (IoBM), Karachi 75190, Pakistan
* Corresponding Author: Tariq Hussain, [email protected]
Received: 24 October 2024, Accepted: 08 January 2025, Published: 18 February 2025  
Abstract
In the therapy of Coronavirus, the drug target is a demanding task to find novel medicine. A bunch of pharmaceutics procedures are employed to recognize these mutual actions. But they are exhausting and high-priced. Keeping this in view, computational procedures are widely approached to determine the mutual action of the medicine and their respective proteins. Many scientists have applied ML approaches to deduce attributes from simplified molecular-input line systems (for medicine) and protein sequences. Such approaches dropped the proteins' chemical, physical, and structural characteristics and the respective medicine. Our job is to undertake deep learning approaches to detect coronavirus enzyme correspondence with the validated Chembl database medicine. The representation of the molecular structure of proteins, medically known as fingerprints, will be done scientifically. Then, a deep learning model will be given training on the pulled-out fingerprints and the properties of molecules to determine the interplay of the medicine with the respective catalyst. The suggested approach will be proficient in recognizing the catalyst's interactivity with the approved database medicine.

Graphical Abstract
Prediction of Coronavirus Inhibitors in Drug Discovery through Deep Learning

Keywords
component
formatting
style
styling
insert
covid

Funding
This work was supported without any funding.

Conflicts of Interest
The authors declare no conflicts of interest. 

Ethical Approval and Consent to Participate
Not applicable.

References
  1. Beck, B. R., Shin, B., Choi, Y., Park, S., & Kang, K. J. C. (2020). Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Journal of Computational Chemistry, 18, 784-790.
    [CrossRef]   [Google Scholar]
  2. Woo, P. C., Huang, Y., Lau, S. K., & Yuen, K.-Y. (2010). Coronavirus genomics and bioinformatics analysis. Virology Journal, 2(8), 1804-1820.
    [CrossRef]   [Google Scholar]
  3. Kuiken, T., et al. (2003). Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. The Lancet, 362(9380), 263-270.
    [CrossRef]   [Google Scholar]
  4. Zaki, A. M., Van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D., & Fouchier, R. A. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New England Journal of Medicine, 367(19), 1814-1820.
    [CrossRef]   [Google Scholar]
  5. Li, Q., et al. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine.
    [CrossRef]   [Google Scholar]
  6. Hossain, M. M., et al. (2020). Current status of global research on novel coronavirus disease (Covid-19): A bibliometric analysis and knowledge mapping. Health Metrics.
    [CrossRef]   [Google Scholar]
  7. Majumdar, S., et al. (2021). Deep Learning-Based Potential Ligand Prediction Framework for COVID-19 with Drug–Target Interaction Model. Journal of Chemical Information and Modeling, 1-13.
    [CrossRef]   [Google Scholar]
  8. Akbar, W., Soomro, A., Hussain, A., Hussain, T., Farman, A., Haq, M. I. U., … Alsagri, R. (2024). Pneumonia Detection: A Comprehensive Study of Diverse Neural Network Architectures using Chest X-Rays. International Journal of Applied Mathematics and Computer Science, 34(4), 679-699.
    [CrossRef]   [Google Scholar]
  9. Allam, Z., & Jones, D. S. (2020). On the coronavirus (COVID-19) outbreak and the smart city network: universal data sharing standards coupled with artificial intelligence (AI) to benefit urban health monitoring and management. Healthcare, 8(1), 46.
    [CrossRef]   [Google Scholar]
  10. Jing, Y., Bian, Y., Hu, Z., Wang, L., & Xie, X.-Q. (2018). Deep learning for drug design: an artificial intelligence paradigm for drug discovery in the big data era. The AAPS Journal, 20(3), 1-10.
    [CrossRef]   [Google Scholar]
  11. Choi, Y., Shin, B., Kang, K., Park, S., & Beck, B. R. (2020). Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model. Viruses, 12(11), 1325.
    [CrossRef]   [Google Scholar]
  12. Liu, T., Siegel, E., & Shen, D. (2022). Deep learning and medical image analysis for COVID-19 diagnosis and prediction. Annual review of biomedical engineering, 24(1), 179-201.
    [CrossRef]   [Google Scholar]
  13. Abdel-Basset, M., Hawash, H., Elhoseny, M., Chakrabortty, R. K., & Ryan, M. (2020). DeepH-DTA: deep learning for predicting drug-target interactions: a case study of COVID-19 drugs repurposing. IEEE Access, 8, 170433-170451.
    [CrossRef]   [Google Scholar]
  14. Jin, W., et al. (2021). Deep learning identifies synergistic drug combinations for treating COVID-19. Proceedings of the National Academy of Sciences, 118(39).
    [CrossRef]   [Google Scholar]
  15. Huang, K., Fu, T., Glass, L. M., Zitnik, M., Xiao, C., & Sun, J. (2020). DeepPurpose: a deep learning library for drug–target interaction prediction. Bioinformatics, 36(22-23), 5545-5547.
    [CrossRef]   [Google Scholar]
  16. You, J., McLeod, R. D., & Hu, P. J. (2019). Predicting drug-target interaction network using deep learning model. Computational Biology and Chemistry, 80, 90-101.
    [CrossRef]   [Google Scholar]
  17. Rahman, A. U., Saqia, B., Alsenani, Y. S., & Ullah, I. (2024). Data Quality, Bias, and Strategic Challenges in Reinforcement Learning for Healthcare: A Survey. International Journal of Data Informatics and Intelligent Computing, 3(3), 24-42. https://orcid.org/0009-0002-4613-5771
    [Google Scholar]
  18. Wang, Y.-B., et al. (2020). A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network. The AAPS Journal, 20(2), 1-9.
    [CrossRef]   [Google Scholar]
  19. Shoaib, M., Sayed, N., Shah, B., Hussain, T., AlZubi, A. A., AlZubi, S. A., & Ali, F. (2023). Exploring transfer learning in chest radiographic images within the interplay between COVID-19 and diabetes. Frontiers in Public Health, 11, 1297909.
    [CrossRef]   [Google Scholar]
  20. Singh, S. K., Chauhan, S., Alsafrani, A., Islam, M., Sherazi, H. I., & Ullah, I. (2024). Optimizing healthcare data quality with optimal features driven mutual entropy gain. Expert Systems, e13737.
    [CrossRef]   [Google Scholar]
  21. Tufail, A. B., Ma, Y. K., Kaabar, M. K., Martínez, F., Junejo, A. R., Ullah, I., & Khan, R. (2021). Deep learning in cancer diagnosis and prognosis prediction: a minireview on challenges, recent trends, and future directions. Computational and Mathematical Methods in Medicine, 2021(1), 9025470.
    [CrossRef]   [Google Scholar]
  22. Sadiq, M. T., Yu, X., Yuan, Z., Zeming, F., Rehman, A. U., Ullah, I., … Xiao, G. (2019). Motor imagery EEG signals decoding by multivariate empirical wavelet transform-based framework for robust brain–computer interfaces. IEEE Access, 7, 171431-171451.
    [CrossRef]   [Google Scholar]
  23. Ahmad, S., Ullah, T., Ahmad, I., Al-Sharabi, A., Ullah, K., Khan, R. A., … Ali, M. S. (2022). A novel hybrid deep learning model for metastatic cancer detection. Computational Intelligence and Neuroscience, 2022(1), 8141530.
    [CrossRef]   [Google Scholar]
  24. MOE. (n.d.). Retrieved from http://www.chemcomp.com/
    [Google Scholar]
  25. Amir-Aslani, A., & Mangematin, V. (2010). The future of drug discovery and development: shifting emphasis towards personalized medicine. Technological Forecasting and Social Change, 77(2), 203-217.
    [CrossRef]   [Google Scholar]
  26. Jayalakshmi, T., Vardhan, K. N., Priya, R., & Vijayalakshmi, K. (2019). In silico analysis and immunodiagnosis of different amino acids using homology modeling. Drug Invention Today, 11(5).
    [Google Scholar]
  27. Johnson, A. (2022). Covid-19’s Impact on Healthcare. Journal of Public Health.
    [Google Scholar]
  28. Roberts, K., Gordon, S., Sherr, L., Stewart, J., Skeen, S., Macedo, A., & Tomlinson, M. (2020). ‘When you are a data collector you must expect anything’. Barriers, boundaries and breakthroughs: insights from the South African data-collection experience. Global Health Promotion, 27(2), 54-62.
    [CrossRef]   [Google Scholar]
  29. Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., … Zhao, S. (2019). Applications of machine learning in drug discovery and development. Nature Reviews Drug Discovery, 18(6), 463-477.
    [CrossRef]   [Google Scholar]
  30. Jia, J., Zhu, F., Ma, X., Cao, Z. W., Li, Y. X., & Chen, Y. Z. (2009). Mechanisms of drug combinations: interaction and network perspectives. Nature Reviews Drug Discovery, 8(2), 111-128.
    [CrossRef]   [Google Scholar]
  31. Chen, X., Yan, C. C., Zhang, X., Zhang, X., Dai, F., Yin, J., & Zhang, Y. (2016). Drug–target interaction prediction: databases, web servers and computational models. Briefings in Bioinformatics, 17(4), 696-712.
    [CrossRef]   [Google Scholar]
  32. Bobrowski, T., Chen, L., Eastman, R. T., Itkin, Z., Shinn, P., Chen, C. Z., … Muratov, E. N. (2021). Synergistic and antagonistic drug combinations against SARS-CoV-2. Molecular Therapy, 29(2), 873-885.
    [CrossRef]   [Google Scholar]
  33. García, E., & Weiss, E. (2020). COVID-19 and Student Performance, Equity, and US Education Policy: Lessons from Pre-Pandemic Research to Inform Relief, Recovery, and Rebuilding. Economic Policy Institute.
    [Google Scholar]
  34. Indicators, S. S. E. (n.d.). THE PRE-COVID LANDSCAPE.
    [Google Scholar]
  35. Mok, K. H. (2022). Impact of COVID-19 on higher education: Critical reflections. Higher Education Policy, 35(3), 563.
    [CrossRef]   [Google Scholar]
  36. Day, T., Chang, I. C. C., Chung, C. K. L., Doolittle, W. E., Housel, J., & McDaniel, P. N. (2021). The immediate impact of COVID-19 on postsecondary teaching and learning. The Professional Geographer, 73(1), 1-13.
    [CrossRef]   [Google Scholar]
  37. Ali, W. (2020). Online and remote learning in higher education institutes: A necessity in light of COVID-19 pandemic. Higher Education Studies, 10(3), 16-25.
    [Google Scholar]
  38. Allan, M., Lièvre, M., Laurenson-Schafer, H., de Barros, S., Jinnai, Y., Andrews, S., … Fitzner, J. (2022). The world health organization COVID-19 surveillance database. International Journal for Equity in Health, 21(Suppl 3), 167.
    [CrossRef]   [Google Scholar]
  39. World Health Organization. (2010). Improving the quality and use of birth, death and cause-of-death information: guidance for a standards-based review of country practices.
    [Google Scholar]
  40. Setel, P. W., Macfarlane, S. B., Szreter, S., Mikkelsen, L., Jha, P., Stout, S., & AbouZahr, C. (2007). A scandal of invisibility: making everyone count by counting everyone. The Lancet, 370(9598), 1569-1577.
    [CrossRef]   [Google Scholar]
  41. Koh, H. K., Geller, A. C., & VanderWeele, T. J. (2021). Deaths from COVID-19. JAMA, 325(2), 133-134.
    [CrossRef]   [Google Scholar]
  42. Hasan, M. N., Haider, N., Stigler, F. L., Khan, R. A., McCoy, D., Zumla, A., … Uddin, M. J. (2021). The global case-fatality rate of COVID-19 has been declining since May 2020. The American Journal of Tropical Medicine and Hygiene, 104(6), 2176.
    [CrossRef]   [Google Scholar]

Cite This Article
APA Style
Khan, T., Hussain, A., Hussain, T., Lin, X., Sharafian, A., Monirul, I.M., & Laila, U. (2025). Prediction of Coronavirus Inhibitors in Drug Discovery through Deep Learning. IECE Transactions on Advanced Computing and Systems, 1(1), 19–31. https://doi.org/10.62762/TACS.2024.974479

Article Metrics
Citations:

Crossref

0

Scopus

0

Web of Science

0
Article Access Statistics:
Views: 90
PDF Downloads: 50

Publisher's Note
IECE stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions
Institute of Emerging and Computer Engineers (IECE) or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
IECE Transactions on Advanced Computing and Systems

IECE Transactions on Advanced Computing and Systems

ISSN: request pending (Online) | ISSN: request pending (Print)

Email: [email protected]

Portico

Portico

All published articles are preserved here permanently:
https://www.portico.org/publishers/iece/

Copyright © 2025 Institute of Emerging and Computer Engineers Inc.